Cargando…
The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
Vasopressors and inotropes (Vs/Is) are widely used in the treatment of cardiogenic shock (CS). Despite improvements in hemodynamic variables and end-organ perfusion, these agents have been associated with an increase in mortality, potentially due to the increased risk of tachyarrhythmias—which we hy...
Autores principales: | Ryu, Rachel, Hauschild, Christopher, Bahjri, Khaled, Tran, Huyentran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680500/ https://www.ncbi.nlm.nih.gov/pubmed/36412905 http://dx.doi.org/10.3390/medsci10040064 |
Ejemplares similares
-
Vasopressors and inotropes in cardiogenic shock: is there room for “adrenaline resuscitation”?
por: Morici, Nuccia, et al.
Publicado: (2016) -
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
por: Bloom, Jason E., et al.
Publicado: (2023) -
Vasopressor stays vasopressor and inotrope stays inotrope!
por: Luckner, Günter, et al.
Publicado: (2008) -
Real-life use of vasopressors and inotropes in cardiogenic shock—observation is necessarily ‘theory-laden’
por: Ray, Samiran, et al.
Publicado: (2016) -
Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis
por: Karami, Mina, et al.
Publicado: (2020)